View from the Thoraxcenter: AHA 22 Late-breaking Science Wrap-up

  • Видео
  • О видео
  • Скачать
  • Поделиться

View from the Thoraxcenter: AHA 22 Late-breaking Science Wrap-up

Visit Radcliffe Cardiology: https://www.radcliffecardiology.com/?utm_source=youtube&utm_medium=organic_social&utm_term=&utm_campaign=DELV-0000&utm_content=youtube Stay updated on the AHA 22 late-breaking data! In this information packed episode of the View from the Thoraxcenter, hosts Dr Joost Daemen and Prof Nicolas Van Mieghem (Thoraxcenter, Erasmus MC, Rotterdam, NL) analyse the data from 10 late-breaking trials presented at the Scientific Sessions. What are the key take-aways from AHA 22? What are the most promising findings? How should we understand the new data in the context of patient care? Discussed trials: 0:29 ISCHEMIA-EXTENDed: Follow-Up Interim Report 4:50 TRANSFORM-HF: Comparative Effectiveness of Torsemide versus Furosemide in Heart Failure: Primary Results of the TRANSFORM-HF Trial 7:14 IRONMAN: Randomized Trial of Intravenous Ferric Derisomaltose in Heart Failure with Reduced Ejection Fraction 9:57 ECMO-CS: Extracorporeal Membrane Oxygenation in the Therapy of Cardiogenic Shock: Primary Results from the Multicenter, Randomized ECMO-CS Trial 14:53 RESPECT-EPA: Randomized Trial for Evaluating Secondary Prevention Efficacy of Combination Therapy - Statin and Eicosapentaenoic Acid 17:41 PRECISION: Sustained Blood Pressure Lowering Effect with the Dual Endothelin Receptor Antagonist Aprocitentan in Resistant Hypertension: Results from a Randomized, Controlled Study Including a Withdrawal Phase 20:21 BrigHTN: Results from a Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Efficacy and Safety of Baxdrostat in Patients with Treatment-Resistant Hypertension 22:38 SPYRAL HTN-ON: Effect of Radiofrequency Renal Denervation on Blood Pressure in the Presence of Antihypertensive Drugs: 6-Month Primary Results from the SPYRAL HTN-ON Med Expansion Randomized Trial 29:49 EARLY-AF: Early Aggressive Invasive Intervention for Atrial Fibrillation 32:04 DOSE VF: Double Sequential External Defibrillation for Refractory Ventricular Fibrillation This content is intended for healthcare professionals only. Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster.
290   |   2 год. назад  |   2 - 0
 

View from the Thoraxcenter: AHA 22 Late-breaking Science Wrap-up

Скачайте изображение (превью) выбрав качество


320x180 480x360 640x480 1280x720

Visit Radcliffe Cardiology:

Stay updated on the AHA 22 late-breaking data!

In this information packed episode of the View from the Thoraxcenter, hosts Dr Joost Daemen and Prof Nicolas Van Mieghem (Thoraxcenter, Erasmus MC, Rotterdam, NL) analyse the data from 10 late-breaking trials presented at the Scientific Sessions.

What are the key take-aways from AHA 22? What are the most promising findings? How should we understand the new data in the context of patient care?

Discussed trials:
0:29 ISCHEMIA-EXTENDed: Follow-Up Interim Report
4:50 TRANSFORM-HF: Comparative Effectiveness of Torsemide versus Furosemide in Heart Failure: Primary Results of the TRANSFORM-HF Trial
7:14 IRONMAN: Randomized Trial of Intravenous Ferric Derisomaltose in Heart Failure with Reduced Ejection Fraction
9:57 ECMO-CS: Extracorporeal Membrane Oxygenation in the Therapy of Cardiogenic Shock: Primary Results from the Multicenter, Randomized ECMO-CS Trial
14:53 RESPECT-EPA: Randomized Trial for Evaluating Secondary Prevention Efficacy of Combination Therapy - Statin and Eicosapentaenoic Acid
17:41 PRECISION: Sustained Blood Pressure Lowering Effect with the Dual Endothelin Receptor Antagonist Aprocitentan in Resistant Hypertension: Results from a Randomized, Controlled Study Including a Withdrawal Phase
20:21 BrigHTN: Results from a Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Efficacy and Safety of Baxdrostat in Patients with Treatment-Resistant Hypertension
22:38 SPYRAL HTN-ON: Effect of Radiofrequency Renal Denervation on Blood Pressure in the Presence of Antihypertensive Drugs: 6-Month Primary Results from the SPYRAL HTN-ON Med Expansion Randomized Trial
29:49 EARLY-AF: Early Aggressive Invasive Intervention for Atrial Fibrillation
32:04 DOSE VF: Double Sequential External Defibrillation for Refractory Ventricular Fibrillation

This content is intended for healthcare professionals only.

Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster.


View from the Thoraxcenter: AHA 22 Late-breaking Science Wrap-up

Чтобы скачать видео "View from the Thoraxcenter: AHA 22 Late-breaking Science Wrap-up" передвинте ползунок вправо



Покажите вашим друзьям, добавьте в соцсети

Ссылка на страницу с видео:

 

Ссылка HTML на страницу с видео:

 

Код для вставки плеера:


  • Комментарии

Комментарии ФБ


Уважаемые друзья!

Источником всего видеоконтента, в том числе проигрывающегося на страницах ресурса ruslar.me, является сторонний видео ресурс, а именно общедоступный видеохостинг YouTube.com, предоставляющий открытый доступ к своему видеоконтенту (используя открытую и общедоступную технологию video API3 youtube.com)!

Проблемы с авторскими правами

Если вам принадлежат авторские права на данное видео, которое было загружено без вашего согласия на YouTube.com, перейдите на страницу этого видео сайта YouTube.com , нажмите на ссылку под проигрывателем Ещё -> "Пожаловаться" -> "Нарушение моих прав" и в выпадающем меню, выбирите, что именно нарушается и нажмите кнопку "Отправить".



Неприемлемый контент

Чтобы сообщить о неприемлемом видео, перейдите на YouTube, нажмите на ссылку под проигрывателем Ещё -> "Пожаловаться" и выберите в "Сообщить о нарушении" что именно вас не устраивает в этом видео. Подробнее о наших правилах читайте в Условиях использования.